Gattei V - Search Results

1

Persistence of monoclonal B-cell expansion and intraclonal diversification despite virus eradication in patients affected by hepatitis C virus-associated lymphoproliferative disorders.

Mazzaro C, Visentini M, Gragnani L, Vit F, Tissino E, Pozzo F, Papotti R, Casato M, Zignego AL, Bittolo T, Zucchetto A, Degan M, Bomben R, Gattei V. Mazzaro C, et al. Among authors: gattei v. Br J Haematol. 2023 Oct;203(2):237-243. doi: 10.1111/bjh.19002. Epub 2023 Jul 25. Br J Haematol. 2023. PMID: 37491625

2

The expression of CD26 and CD40 ligand is mutually exclusive in human T-cell non-Hodgkin's lymphomas/leukemias.

Carbone A, Gloghini A, Zagonel V, Aldinucci D, Gattei V, Degan M, Improta S, Sorio R, Monfardini S, Pinto A. Carbone A, et al. Among authors: gattei v. Blood. 1995 Dec 15;86(12):4617-26. Blood. 1995. PMID: 8541553 Free article.

3

Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1.

Carbone A, Gloghini A, Gattei V, Degan M, Improta S, Aldinucci D, Canzonieri V, Perin T, Volpe R, Gaidano G, Zagonel V, Pinto A. Carbone A, et al. Among authors: gattei v. Blood. 1997 May 15;89(10):3787-94. Blood. 1997. PMID: 9160685 Free article.

4

Cytokine-receptors repertoire in a pre-osteoclast cell line.

Gattei V, Aldinucci D, Degan M, De Iuliis A, Rossi FM, Pinto A. Gattei V, et al. Br J Haematol. 1997 Jun;97(4):934-6. Br J Haematol. 1997. PMID: 9217203 Free article. No abstract available.

5

Characterization of anti-CD138 monoclonal antibodies as tools for investigating the molecular polymorphism of syndecan-1 in human lymphoma cells.

Gattei V, Godeas C, Degan M, Rossi FM, Aldinucci D, Pinto A. Gattei V, et al. Br J Haematol. 1999 Jan;104(1):152-62. doi: 10.1046/j.1365-2141.1999.01132.x. Br J Haematol. 1999. PMID: 10027728 Free article.

6

The RET receptor tyrosine kinase, but not its specific ligand, GDNF, is preferentially expressed by acute leukaemias of monocytic phenotype and is up-regulated upon differentiation.

Gattei V, Degan M, Rossi FM, De Iuliis A, Mazzocco FT, Cesa E, Aldinucci D, Zagonel V, Pinto A. Gattei V, et al. Br J Haematol. 1999 Apr;105(1):225-40. Br J Haematol. 1999. PMID: 10233387 Free article.

7

CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation.

Gattei V, Degan M, Rossi FM, de Iuliis A, Mazzocco FT, Serraino D, Zagonel V, Aldinucci D, Pinto A. Gattei V, et al. Leuk Lymphoma. 1999 Sep;35(1-2):21-35. doi: 10.3109/10428199909145702. Leuk Lymphoma. 1999. PMID: 10512160 Review.

8

Normalizing complementary DNA by quantitative reverse transcriptase-polymerase chain reaction of beta2-microglobulin: molecular monitoring of minimal residual disease in acute promyelocytic leukemia.

Degan M, Mazzocco FT, Di Francia R, Rossi FM, Pinto A, Gattei V. Degan M, et al. Among authors: gattei v. Diagn Mol Pathol. 2000 Jun;9(2):98-109. doi: 10.1097/00019606-200006000-00006. Diagn Mol Pathol. 2000. PMID: 10850546

9

In vitro and in vivo effects of 2'-deoxycoformycin (Pentostatin) on tumour cells from human gammadelta+ T-cell malignancies.

Aldinucci D, Poletto D, Zagonel V, Rupolo M, Degan M, Nanni P, Gattei V, Pinto A. Aldinucci D, et al. Among authors: gattei v. Br J Haematol. 2000 Jul;110(1):188-96. doi: 10.1046/j.1365-2141.2000.02129.x. Br J Haematol. 2000. PMID: 10930997 Free article.

10

CD30L up-regulates CD30 and IL-4 expression by T cells.

Rossi FM, Degan M, Mazzocut-Zecchin L, Di Francia R, Aldinucci D, Pinto A, Gattei V. Rossi FM, et al. Among authors: gattei v. FEBS Lett. 2001 Nov 23;508(3):418-22. doi: 10.1016/s0014-5793(01)03076-9. FEBS Lett. 2001. PMID: 11728464 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

288 results

Search Page